SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-001246
Filing Date
2003-05-16
Accepted
2003-05-16 16:47:01
Documents
1
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sch13ga_051603.txt SC 13G/A 12736
  Complete submission text file 0000947871-03-001246.txt   14878
Mailing Address 401 QUEEN ANNE AVE NORTH SEATTLE WA 98109
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 2062989400
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

IRS No.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35589 | Film No.: 03708952
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 2127396400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

IRS No.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231